| Literature DB >> 30417126 |
Yoon-Jin Kim1, Dong Hee Seo1, Seung Hee Lee1, Sung-Hoon Lee1, Geun-Ho An1, Hee-Jin Ahn1, Daekee Kwon1, Kwang-Won Seo1, Kyung-Sun Kang1,2.
Abstract
Developing treatments that inhibit skin aging is an important research project. Rejuvenation, which focuses on prevention of skin aging, is one of the major issues. Recent studies suggested that mesenchymal stem cells (MSCs) secrete many cytokines, which are important in wound healing. In this study, we investigated the effect of human umbilical cord blood-derived mesenchymal stem cells conditioned media (USC-CM) in cutaneous wound healing and collagen synthesis. We found that USC-CM has many useful growth factors associated with skin rejuvenation, such as Epithelial Growth Factor (EGF), basic Fibroblast Growth Factor (bFGF), Platelet Derived Growth Factor (PDGF), Hepatocyte Growth Factor (HGF), Collagen type 1, and especially, one of the rejuvenation factors, the growth differentiation factor-11 (GDF-11). Our in vitro results showed that USC-CM stimulate growth and extracellular matrix (ECM) production of Human Dermal Fibroblasts (HDFs) compared to those of other MSCs conditioned media (CM) from different origins. Moreover, we evaluated the roles of GDF-11. The results showed that GDF-11 accelerates growth, migration and ECM production of HDFs. Our In vivo results showed that topical treatment of USC-CM showed anti-wrinkle effect and significantly increased dermal density in women. In conclusion, USC-CM has various useful growth factors including GDF-11 that can stimulate skin rejuvenation by increasing growth and ECM production of HDFs.Entities:
Keywords: Conditioned media; Cosmetics; Mesenchymal stem cells; Skin; Umbilical cord blood-derived mesenchymal stem cells conditioned media (USC-CM)
Year: 2018 PMID: 30417126 PMCID: PMC6205340 DOI: 10.1016/j.bbrep.2018.10.007
Source DB: PubMed Journal: Biochem Biophys Rep ISSN: 2405-5808
Fig. 1Selection of conditioned media (CM). (A) Human antibody array analysis of USC-CM. (B) Time line of cytokine expression of USC-CM. (C) HDFs growth and total protein content after various CM (CTL; KSB-2 media, HDF-CM, AD-MSC-CM and USC-CM) (x100). Data are represented as the mean ± SEM. **P < 0.01.
Fig. 2USC-CM promoted HDFs migration and ECM production in vitro. (A) Migration of HDFs after CM culture. USC-CM is most effective in HDFs migration. (x40) (B) ECM gene expression of HDFs treated with each CM (CTL; KSB-2 media, HDF-CM, AD-MSC-CM and USC-CM). (C) ECM secretion of HDFs treated with each CM. Data are represented as the mean ± SEM. *P < 0.05, **P < 0.01 and ***P < 0.001.
Fig. 3GDF-11 expression of hMSCs. (A) Gene expression of GDF-11 in hMSCs with each culture condition. (B) The level of production GDF-11 was measured using ELISA kit. Data are represented as the mean ± SEM. **P < 0.01 and ***P < 0.001.
Fig. 4GDF-11 promoted HDFs migration and ECM production in vitro. (A) The proliferation of HDFs treated GDF-11 (0.01 μg/ml, 0.1 μg ml) treatment. (B) qRT-PCR analysis for ECM expression HDFs threated with GDF-11. (C) Time-course growth rate of HDFs following treated with GDF-11. (D) Scratch assay of HDFs following treated with GDF-11 for 72 h. (E) Western blot analysis for ECM secretion of HDFs threated with GDF-11. Data are represented as the mean ± SEM. *P < 0.05, **P < 0.01 and ***P < 0.001.